ArticleScientific reports2025
Genetic diversity analysis of IVM resistant Haemonchus contortus in sheep in inner Mongolia of China.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Haemonchus contortus is widely distributed in the world, which is seriously harmful to small ruminants and has serious resistance to common anthelmintics. Over time, the prevalence and intensity of host infection with this parasite have gradually increased, so it is necessary to study the phylogenetic and genetic changes of single anthelmintic resistant strains. This study is the first to analyze the genetic diversity and population structure about IVM-resistant H.contortus (L3,egg, adult, n = 30 ) in Inner Mongolia, China. The H.contortus were identified to IVM resistance and cultured by fecal egg count reduction test, larval development inhibition test and larval locomotor behaviour test. The complete sequence of ITS2 ( second internal transcribed spacer ) and partial sequence of nad4 ( nicotinamide dehydrogenase subunit 4 gene ) in L3, adult and egg were amplified. At the same time, compared with the ITS2 and nad4 partial sequences of H.contortus reported in NCBI database to carry out phylogenetic analysis and haplotype determination, so as to further study the variation and population genetic diversity of IVM-RR samples. The samples were identified as H.contortus resistant to IVM. Phylogenetic analyses of ITS2 of IVM-RR and other H.contortus showed that they were from the same branch, genetic relationship was close, the intraspecific was relatively conserved, and no significant correlation with AR. There was no significant difference between different stages of development of the samples. In addition, from the 30 nad4 gene sequences of IVM-RR samples obtained 13 haplotypes, and the 169th base site in 70% of the nad4 gene was mutated. The nucleotide diversity was 0.00623 and haplotype diversity was 0.926. IVM-RR compared with five countries' H.contortus nad4, found that the genetic differentiation level of the IVM-RR population was relatively low with the China and Pakistan populations, and the Fixation index (Fst) were 0.10957 and 0.17262, respectively. The genetic differentiation levels with Bangladesh, Greece and France populations were higher, and the Fst values were 0.46978,0.61825 and 0.98101. Perhaps the population structure differentiation were correlated with regional localization and anthelmintic frequency treatment. In this report, we analyzed the genetic diversity and population differentiation of IVM resistant H.contortus at different developmental stages, and obtained resistant samples' haplotypes, hoping to provide a new direction for the study of AR and vaccine research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.